BACKGROUND: Refugees are highly vulnerable populations with limited access to health care services. The United States accepts 50,000-75,000 refugees for resettlement annually. Despite residing in camps and other locations where vaccine-preventable disease outbreaks, such as measles, occur frequently, refugees are not required to have any vaccinations before they arrive in the United States. PURPOSE: We estimated the medical and public-health response costs of a case of measles imported into Kentucky by a refugee. METHODS: The Kentucky Refugee Health Coordinator recorded the time and labor of local, state, and some federal personnel involved in caring for the refugee and implementing the public health response activities. Secondary sources were used to estimate the labor and medical care costs of the event. RESULTS: The total costs to conduct the response to the disease event were approximately $25,000. All costs were incurred by government, either public health department or federal, because refugee health costs are paid by the federal government and the event response costs are covered by the public health department. CONCLUSION: A potentially preventable case of measles that was imported into the United States cost approximately $25,000 for the public health response. RECOMMENDATION: To maintain the elimination of measles transmission in the United States, U.S.-bound refugees should be vaccinated overseas. A refugee vaccination program administered during the overseas health assessment has the potential to reduce the risk of importation of measles and other vaccine-preventable disease and would eliminate costs associated with public health response to imported cases and outbreaks. Published by Elsevier Ltd.
BACKGROUND: Refugees are highly vulnerable populations with limited access to health care services. The United States accepts 50,000-75,000 refugees for resettlement annually. Despite residing in camps and other locations where vaccine-preventable disease outbreaks, such as measles, occur frequently, refugees are not required to have any vaccinations before they arrive in the United States. PURPOSE: We estimated the medical and public-health response costs of a case of measles imported into Kentucky by a refugee. METHODS: The Kentucky Refugee Health Coordinator recorded the time and labor of local, state, and some federal personnel involved in caring for the refugee and implementing the public health response activities. Secondary sources were used to estimate the labor and medical care costs of the event. RESULTS: The total costs to conduct the response to the disease event were approximately $25,000. All costs were incurred by government, either public health department or federal, because refugee health costs are paid by the federal government and the event response costs are covered by the public health department. CONCLUSION: A potentially preventable case of measles that was imported into the United States cost approximately $25,000 for the public health response. RECOMMENDATION: To maintain the elimination of measles transmission in the United States, U.S.-bound refugees should be vaccinated overseas. A refugee vaccination program administered during the overseas health assessment has the potential to reduce the risk of importation of measles and other vaccine-preventable disease and would eliminate costs associated with public health response to imported cases and outbreaks. Published by Elsevier Ltd.
Authors: Emily P Hyle; Sowmya R Rao; Emily S Jentes; Amy Parker Fiebelkorn; Stefan H F Hagmann; Allison Taylor Walker; Rochelle P Walensky; Edward T Ryan; Regina C LaRocque Journal: Ann Intern Med Date: 2017-05-16 Impact factor: 25.391
Authors: Clelia Pezzi; Audrey McCulloch; Heesoo Joo; Jennifer Cochran; Laura Smock; Ellen Frerich; Blain Mamo; Kailey Urban; Stephen Hughes; Colleen Payton; Kevin Scott; Brian Maskery; Deborah Lee Journal: Vaccine Date: 2018-02-01 Impact factor: 3.641
Authors: Margaret S Coleman; Karen J Marienau; Nina Marano; Suzanne M Marks; Martin S Cetron Journal: Travel Med Infect Dis Date: 2013-11-08 Impact factor: 6.211
Authors: Anita W M Suijkerbuijk; Tom Woudenberg; Susan J M Hahné; Laura Nic Lochlainn; Hester E de Melker; Wilhelmina L M Ruijs; Anna K Lugnér Journal: Emerg Infect Dis Date: 2015-11 Impact factor: 6.883
Authors: Margaret S Coleman; Heather M Burke; Bethany L Welstead; Tarissa Mitchell; Eboni M Taylor; Dmitry Shapovalov; Brian A Maskery; Heesoo Joo; Michelle Weinberg Journal: Hum Vaccin Immunother Date: 2017-01-09 Impact factor: 3.452
Authors: Janetta E Skarp; Laura E Downey; Julius W E Ohrnberger; Lucia Cilloni; Alexandra B Hogan; Abagael L Sykes; Susannah S Wang; Hiral Anil Shah; Mimi Xiao; Katharina Hauck Journal: Appl Health Econ Health Policy Date: 2021-06-11 Impact factor: 3.686